School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia.
BMC Complement Altern Med. 2013 Dec 9;13:346. doi: 10.1186/1472-6882-13-346.
The frequent occurrences of antibiotic-resistant biofilm forming pathogens have become global issue since various measures that had been taken to curb the situation led to failure. Euphorbia hirta, is a well-known ethnomedicinal plant of Malaysia with diverse biological activities. This plant has been used widely in traditional medicine for the treatment of gastrointestinal, bronchial and respiratory ailments caused by infectious agents.
In the present study, chemical compositions of methanol extract of E. hirta L. aerial part was analyzed by gas chromatography and gas chromatography coupled to mass spectrometry. A relevant in vitro model was developed to assess the potency of the E. hirta extract to inhibit the bacterial biofilm formation as well as to eradicate the established biofilms. Besides biofilm, E. hirta extract was also evaluated for the inhibition efficacy on planktonic cells using tetrazolium microplate assay. For these purposes, a panel of clinically resistant pathogens and American type culture collection (ATCC) strains were used.
The methanolic extract of aerial part of E. hirta was predominantly composed of terpenoid (60.5%) which is often regarded as an active entity accountable for the membrane destruction and biofilm cell detachment. The highest antibacterial effect of crude E. hirta extract was observed in the clinical isolates of Pseudomonas aeruginosa with minimum inhibitory concentration (MIC) value of 0.062 mg/ml. The extract also displayed potent biofilm inhibition and eradication activity against P. aeruginosa with minimum biofilm inhibition concentration (MBIC) and minimum biofilm eradication concentration (MBEC) values of 0.25 mg/ml and 0.5 mg/ml, respectively.
The crude methanol extract of E. hirta has proven to have interesting and potential anti-biofilm properties. The findings from this study will also help to establish a very promising anti-infective phytotherapeutical to be exploited in the pharmaceutical industries.
由于各种旨在遏制这一局面的措施都以失败告终,经常出现抗生素耐药生物膜形成病原体已成为全球性问题。大飞扬草是马来西亚一种广为人知的药用植物,具有多种生物活性。这种植物在传统医学中被广泛用于治疗由感染因子引起的胃肠道、支气管和呼吸道疾病。
在本研究中,通过气相色谱和气相色谱-质谱联用分析了大飞扬草地上部分甲醇提取物的化学成分。建立了相关的体外模型,以评估大飞扬草提取物抑制细菌生物膜形成以及清除已建立的生物膜的能力。除生物膜外,还通过噻唑蓝微量板法评估大飞扬草提取物对浮游细胞的抑制效果。为此,使用了一组临床耐药病原体和美国典型培养物保藏中心(ATCC)菌株。
大飞扬草地上部分的甲醇提取物主要由萜类化合物(60.5%)组成,萜类化合物通常被认为是一种活性物质,负责破坏膜和生物膜细胞脱落。粗提大飞扬草提取物对铜绿假单胞菌临床分离株的抗菌作用最强,最小抑菌浓度(MIC)值为 0.062mg/ml。该提取物还显示出对铜绿假单胞菌的强大生物膜抑制和清除活性,最低生物膜抑制浓度(MBIC)和最低生物膜清除浓度(MBEC)值分别为 0.25mg/ml 和 0.5mg/ml。
大飞扬草粗甲醇提取物已被证明具有有趣和潜在的抗生物膜特性。本研究的结果也将有助于建立一种非常有前途的抗感染植物疗法,供制药行业开发利用。